Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats
Author(s) -
Weili Zhu,
Shenjun Wang,
Meng-Meng Liu,
Haishui Shi,
Ruoxi Zhang,
Jianfeng Liu,
Zengbo Ding,
Lin Lü
Publication year - 2013
Publication title -
journal of psychiatry and neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.767
H-Index - 99
eISSN - 1488-2434
pISSN - 1180-4882
DOI - 10.1503/jpn.120228
Subject(s) - antidepressant , nmda receptor , prefrontal cortex , neuroscience , glutamatergic , pharmacology , ampa receptor , behavioural despair test , gsk 3 , neurotransmission , hippocampus , glutamate receptor , medicine , biology , receptor , kinase , biochemistry , cognition
Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists exert fast-acting antidepressant effects, providing a promising way to develop a new classification of antidepressant that targets the glutamatergic system. In the present study, we examined the potential antidepressant action of 7-chlorokynurenic acid (7-CTKA), a glycine recognition site NMDA receptor antagonist, in a series of behavioural models of depression and determined the molecular mechanisms that underlie the behavioural actions of 7-CTKA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom